Monte Rosa Therapeutics Inc (GLUE)
SG&A Expenses
$10.13M
Quarterly · Period ending: · USD
GLUE SG&A Expenses
Latest reported$10.13Mperiod ending
Latest reported$10.13Mperiod ending
GLUE Quarterly SG&A Expenses ($478.00K → $10.13M)
Quarterly SG&A Expenses
High-resolution chart · PNG
GLUE sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 10,134,000 | |
| 10,175,000 | |
| 10,517,000 | |
| 9,065,000 | |
| 8,095,000 | |
| 8,703,000 | |
| 8,777,000 | |
| 8,127,000 | |
| 9,282,000 | |
| 8,985,000 | |
| 7,728,000 | |
| 8,661,000 | |
| 8,145,000 | |
| 7,504,000 | |
| 7,621,000 | |
| 7,020,000 | |
| 6,295,000 | |
| 6,387,000 | |
| 5,257,000 | |
| 4,753,000 | |
| 3,486,000 | |
| 2,231,000 | |
| 2,073,000 | |
| 914,000 | |
| 541,000 | |
| 478,000 |